Drug formula used for promoting skin wound healing

A technology of wound healing and medicine, applied in the field of medicine formulation, can solve problems such as improper treatment and death

Inactive Publication Date: 2019-09-10
SHANDONG ACADEMY OF PHARMACEUTICAL SCIENCES
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Improper handling can even cause death

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0010] The present invention is specifically implemented in the following ways, and the present invention is further described. These examples are only for the purpose of illustration, and do not limit the protection scope of the present invention.

[0011] A pharmaceutical formulation for promoting skin wound healing, characterized in that:

[0012] The pharmaceutical formula comprises vitamin C injection (5ml: 1g), vitamin B1 injection (1ml: 50mg), vitamin B6 injection (1ml: 50mg) and racemic anisodamine hydrochloride injection (1ml: 10mg).

[0013] Said drugs are in proportion and in parts by weight, 30 parts of vitamin C injection, 10 parts of vitamin B1 injection, 10 parts of vitamin B6 injection, and 10 parts of racemic anisodamine hydrochloride injection are mixed and stirred evenly.

[0014] The method of using the medicine is to spray on the surface of the gauze with a spraying device and apply it on the surface of the wound.

[0015] The above are only preferred imp...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a drug formula used for promoting skin wound healing, which belongs to the field of a drug formula. The formula is characterized in that the formula includes, by weight, 40-60 parts of a vitamin C injection (5 ml:1 g), 10-20 parts of a vitamin B1 injection (1 ml:50 mg), 10-20 parts of a vitamin B6 injection (1 ml:50 mg), and 10-20 parts of a raceanisodamine hydrochloride injection (1 ml:10 mg). The drug formula is mainly used for treatment of diabetic foot and bedsore, and has good effects of being resistant to inflammation, relieving pain, controlling infection and ulceration, improving microcirculation, and promoting wound healing.

Description

technical field [0001] The invention belongs to the field of pharmaceutical formulations, in particular to a pharmaceutical formulation for promoting skin wound healing. Background technique [0002] Diabetic patients due to peripheral neuropathy and peripheral vascular disease combine excessive mechanical pressure, which can cause damage and deformity of the soft tissue and bone joint system of the foot, and then cause a series of foot problems, from mild neurological symptoms to severe ulcers , infection, vascular disease, Charcot arthropathy, and neuropathic fractures, which in turn make it difficult for damaged tissue to heal. [0003] Pressure sores, also known as pressure ulcers or decubitus ulcers, are due to long-term pressure on local tissues, resulting in continuous ischemia, hypoxia, and malnutrition, resulting in tissue ulceration and necrosis. [0004] Burns are the most common surgical injuries when flat or standing. In mild cases, it can damage the skin, and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/375A61K31/51A61K31/4415A61K31/46A61P17/02A61P3/10
CPCA61K31/375A61K31/4415A61K31/46A61K31/51A61P3/10A61P17/02A61K2300/00
Inventor 张世亮梁大连
Owner SHANDONG ACADEMY OF PHARMACEUTICAL SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products